{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-014878","form_type":"8-K","ticker":"COCH","cik":"0001840877","company_name":"Envoy Medical, Inc.","filed_at":"2026-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.491548+00:00","generated_at":"2026-05-16T03:22:26.690014+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Envoy Medical grants CEO 200K and CFO 15K options at $0.53","bullets":["CEO Brent Lucas received options for 200,000 shares; Interim CFO Robert Potashnick received 15,000 shares.","Exercise price set at $0.53 per share (closing price on Feb 5, 2026).","Vesting: 25% after one year, remainder pro rata over next 36 months; options expire 10 years from award date.","Options granted under Envoy Medical's 2023 Equity Incentive Plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-014878","json":"https://secwatch.observer/filing/0001213900-26-014878.json","markdown":"https://secwatch.observer/filing/0001213900-26-014878.md","text":"https://secwatch.observer/filing/0001213900-26-014878.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000121390026014878/0001213900-26-014878-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000121390026014878/ea0276618-8k_envoy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:22:26.690014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}